Paroxysmal Supraventricular Tachycardia (PSVT)

Paroxysmal Supraventricular Tachycardia (PSVT) is the indication for 6 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as: PVST · Paroxysmal Supraventricular Tachycardia · Tachycardia; Paroxysmal, Supraventricular
Classified under: Cardiovascular Diseases
Indicated drugs: Adenosine
Diltiazem
Hydroquinidine
Phenylephrine
Propafenone
Verapamil

Resolves to

Vocabularies

MeSHM000677170ICD-10I47.1SNOMED CT195074009MedDRA10034044UMLSC0030590

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

8Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Paroxysmal Supraventricular Tachycardia (PSVT) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.